Skip to main content
ANAB
NASDAQ Life Sciences

Officer Dennis Mulroy Files to Sell Additional $608K in Stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$63.15
Mkt Cap
$1.838B
52W Low
$11.402
52W High
$72.36
52W Position info
454% above low
Off High info
13% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

ANAB has more than doubled off its 52-week low of $11.402 on elevated volume (1.9× avg).

Summary

Officer Dennis Mulroy has filed a Form 144 to sell $608,183 in company stock, adding to a recent trend of insider dispositions.


Key Events · Ownership and Investor Activity · ANAB

  • Officer Files to Sell Stock

    Officer Dennis Mulroy filed a Form 144 indicating intent to sell 10,000 shares of common stock, valued at approximately $608,183.

  • Continuation of Selling Pattern

    This filing extends a recent trend of significant insider selling by Mr. Mulroy, who has sold over $17.4 million in shares over the last three months.

  • Shares from Option Exercise

    The shares intended for sale were acquired through a stock option exercise on the same day as the filing.

  • Conflicting Capital Signals

    The ongoing insider selling contrasts with the company's recently announced $100 million share repurchase program.


Analysis · ANAB · Life Sciences

This Form 144 filing indicates Officer Dennis Mulroy's intent to sell an additional $608,183 worth of common stock. This transaction adds to a consistent pattern of significant insider selling by Mr. Mulroy, who has disposed of over $17.4 million in shares over the past three months. The continued insider selling could be viewed negatively by investors, especially as it occurs after the company announced a $100 million share repurchase program in May, creating mixed signals about management's long-term outlook and capital allocation strategy.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ANAB was trading at $63.15 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $11.40 to $72.36. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ANAB - Latest Insights

ANAB
Nov 18, 2026, 7:03 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $47.74
Real-time Price: $48.56 info
Change: +$0.820 (+2%) info
Market Cap: $1.409B info
ANAB
Nov 18, 2026, 6:56 PM EST
Filing Type: 4
Importance Score:
8
Price at Filing: $47.06
Real-time Price: $48.56 info
Change: +$1.50 (+3%) info
Market Cap: $1.409B info
ANAB
Nov 12, 2026, 4:21 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $47.77
Real-time Price: $48.56 info
Change: +$0.790 (+2%) info
Market Cap: $1.409B info
ANAB
Nov 12, 2026, 4:16 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $47.77
Real-time Price: $48.56 info
Change: +$0.790 (+2%) info
Market Cap: $1.409B info
ANAB
Oct 20, 2026, 3:49 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $45.00
Real-time Price: $48.56 info
Change: +$3.56 (+8%) info
Market Cap: $1.409B info